Cohera Medical, Inc.® aims to fulfill the market demand for a strong, safe tissue adhesive by developing a revolutionary line of surgical adhesives and wound management products. Our products are based on a unique chemical design that is purely synthetic, fully resorbable, safe for internal use, easy to use, and generates a very strong bond. The basic chemistry can be formulated for use in a wide variety of surgical applications including plastic surgery, general surgery, and orthopedic surgery.

Our lead product under development, TissuGlu®, is an easy-to use, resorbable adhesive that positions tissues for optimal healing while minimizing fluid accumulation. Its first target indication is the reduction or elimination of seroma formation following abdominoplasty procedures.

LATEST NEWS

July 12, 2010

Cohera Medical, Inc.® CEO Patrick Daly Named Finalist In Ernst & Young Entrepreneur Of The Year Awards

more

May 5, 2010

Top-Line Human Clinical Study Results Demonstrate Safety and Preliminary Effectiveness of Cohera Medical’s TissuGlu®

more